email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
3211 - 3225
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Generon Announces SPA for US Phase III Trial of Neutropenia Drug
$5.00
Available
Gentris and Shanghai Institute Sign MOU for Biomarker Collaboration
$5.00
Available
China's State Council Endorses CFDA's New Foreign Clinical Trial Data Policies
$5.00
Available
Shanghai Pharma in Second Round Bidding in $1.5 Billion Cardinal China Deal
$5.00
Available
Beijing is Home to Gates-Backed $100 Million Global Health Institute
$5.00
Available
Zhejiang Huahai Raises $152 Million for New Biopharma Facility
$5.00
Available
Hong Kong's Jacobson Pharma Raises $64 Million for M&A
$5.00
Available
ImmunoMet, a US HanAll Spinoff, Starts Clinical Trial of Cancer Drug
$5.00
Available
Fosun Pharma in $350 Million Auction to Acquire India's Symbiotec Pharma
$5.00
Available
MicroPort/LivaNova JV's Pacemaker Approved for China Use
$5.00
Available
Zai Labs Starts China Phase III Trial of Lead Drug in Ovarian Cancer
$5.00
Available
CR Gosun In-Licenses Antibiotic from Basilea in $153 Million Deal
$5.00
Available
Novo Nordisk Approved to Launch New Diabetes Treatment in China
$5.00
Available
Simcere to Market Four Amgen Biosimilars in China
$5.00
Available
Ping An Pays $245 Million for Stake in Japan's Tsumura, a TCM Company
$5.00
Available